Canadian Sec - Delayed Quote CAD

Rapid Dose Therapeutics Corp. (DOSE.CN)

0.1900
0.0000
(0.00%)
At close: May 9 at 11:23:59 AM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
2/29/2024
2/28/2023
2/28/2022
2/28/2021
Total Revenue
1,609.2510
1,020.4240
718.2980
1,751.9160
755.2010
Cost of Revenue
649.4220
457.0150
345.8940
407.1190
55.3510
Gross Profit
959.8290
563.4090
372.4040
1,344.7970
699.8500
Operating Expense
4,937.6520
3,640.7360
3,916.1790
5,646.6570
2,334.5040
Operating Income
-3,977.8230
-3,077.3270
-3,543.7750
-4,301.8600
-1,634.6540
Net Non Operating Interest Income Expense
-1,198.8810
-661.4540
-264.6400
-133.1180
-142.5610
Other Income Expense
--
-567.7190
-1.6100
-4,052.4710
-28.0430
Pretax Income
-5,744.4230
-4,306.5000
-3,810.0250
-8,487.4490
-1,805.2580
Net Income Common Stockholders
-5,776.5450
-4,306.5000
-3,810.0250
-8,487.4490
-1,805.2580
Diluted NI Available to Com Stockholders
-5,776.5450
-4,306.5000
-3,810.0250
-8,487.4490
-1,805.2580
Basic EPS
-0.04
-0.04
-0.04
-0.08
-0.02
Diluted EPS
-0.04
-0.04
-0.04
-0.08
-0.02
Basic Average Shares
120,576.8620
104,963.7990
103,416.1800
100,216.2320
77,787.3090
Diluted Average Shares
120,576.8620
104,963.7990
103,416.1800
100,216.2320
77,787.3090
Total Operating Income as Reported
--
-3,738.7810
-3,808.4150
-4,435.3410
-1,777.2150
Total Expenses
5,587.0740
4,097.7510
4,262.0730
6,053.7760
2,389.8550
Interest Income
--
--
0
0.3630
0
Interest Expense
1,198.8810
661.4540
264.6400
133.4810
142.5610
Net Interest Income
-1,198.8810
-661.4540
-264.6400
-133.1180
-142.5610
Net Income from Continuing & Discontinued Operation
-5,776.5450
-4,306.5000
-3,810.0250
-8,487.4490
-1,805.2580
Normalized Income
-5,208.8260
-3,738.7810
-3,808.4150
-4,426.5220
-1,777.2150
EBIT
-4,545.5420
-3,645.0460
-3,545.3850
-8,353.9680
-1,662.6970
EBITDA
-4,157.1850
-3,024.7360
-2,917.9410
-7,588.1610
-987.2290
Reconciled Cost of Revenue
675.8970
457.0150
345.8940
407.1190
55.3510
Reconciled Depreciation
361.8820
620.3100
627.4440
765.8070
675.4680
Net Income from Continuing Operation Net Minority Interest
-5,776.5450
-4,306.5000
-3,810.0250
-8,487.4490
-1,805.2580
Total Unusual Items Excluding Goodwill
-567.7190
-567.7190
-1.6100
-4,060.9270
-28.0430
Total Unusual Items
-567.7190
-567.7190
-1.6100
-4,060.9270
-28.0430
Normalized EBITDA
-3,589.4660
-2,457.0170
-2,916.3310
-3,527.2340
-959.1860
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
2/28/2021 - 2/10/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DTC.CN Defence Therapeutics Inc.
0.9500
-4.04%
 
PHRM.CN PharmaTher Holdings Ltd.
0.2150
-2.27%
 
PHRRF PharmaTher Holdings Ltd.
0.1570
+3.09%
 
STOK Stoke Therapeutics, Inc.
9.36
+3.43%
 
NUVL Nuvalent, Inc.
69.85
-2.44%
 
ACLX Arcellx, Inc.
57.55
+2.29%
 
RVMD Revolution Medicines, Inc.
40.42
-3.56%
 
PCVX Vaxcyte, Inc.
31.16
-0.92%
 
MNMD Mind Medicine (MindMed) Inc.
6.15
-4.80%
 
CRSP CRISPR Therapeutics AG
35.62
-1.44%